EYEGENIX
Eyegenix, LLC develops a biosynthetic artificial corneal material for transplantation to cure corneal blindness. The company was incorporated in 2009 and is based in Honolulu, Hawaii. Eyegenix, LLC operates as a subsidiary of Cellular Bioengineering, Inc.
EYEGENIX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2009-01-01
Address:
Honolulu, Hawaii, United States
Country:
United States
Website Url:
http://www.eyegenix.com
Total Employee:
1+
Status:
Closed
Contact:
(808)949-2208
Technology used in webpage:
SPF LetsEncrypt Nginx GoDaddy DNS Pound Sterling Japanese Yen Gravity Forms Digital Ocean Plesk Time Warner
Similar Organizations
Axela
Axela develops tools and content that simplify multiplex biomarker detection for translational research and diagnostic testing operations.
Enzium
Enzium develops fluorescent based reagents for selective protease.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Quantason
Quantason develops bi-modal US/IDUS™ platform technology for diagnostic imaging and active screening.
Current Employees Featured
Founder
Official Site Inspections
http://www.eyegenix.com
- Host name: 138.197.6.171
- IP address: 138.197.6.171
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
More informations about "Eyegenix"
Eyegenex
Dr. Robert Rothman engages in a captivating dialogue with Dr. Prasad Sunkara, CEO of Eyegenex. Contact Us. Contact to receive updates, news, and more. Email. Contact. Eyegenex. A San Diego Pharmaceutical Company. A Seed To …See details»
Eyegenex - LinkedIn
Eyegenex | 80 followers on LinkedIn. Pioneering treatments for Glaucoma and Diabetic Retinopathy to prevent blindness | Glaucoma is the leading cause of blindness and is often related to high ...See details»
Eyegenex 2025 Company Profile: Valuation, Funding
Eyegenex General Information Description. Developer of therapeutics designed to address unmet needs in ophthalmic diseases. The company offers a pipeline …See details»
NuFund Venture Group Highlights Eyegenex’s Innovative …
Jul 15, 2024 Eyegenex is a leading biotechnology company focused on developing innovative treatments for a range of eye conditions. Utilizing advanced gene and peptide therapy, …See details»
Prasad Sunkara, Ph. D - Co Founder and Chief …
Managing Director, Seed to Fruit Fund · Dr. Sunkara is an accomplished leader in the life sciences and biotech sectors, with extensive experience spanning …See details»
Eyegenix 2025 Company Profile: Valuation, Funding & Investors
Eyegenix General Information Description. Operator of a regenerative medicine company intended to develop a biosynthetic cornea for human transplantation. The company's product …See details»
CU Ophthalmology Researchers Create Company to Advance …
Jun 7, 2023 Ram Nagaraj, PhD, professor in the University of Colorado Department of Ophthalmology, envisions a future where ophthalmologists can prevent vision loss associated …See details»
Eyegenex - Products, Competitors, Financials, Employees, …
Eyegenex is also developing a second product, a peptide therapy for the treatment of Acute angle glaucoma (AAG), a disease that needs immediate intervention by surgery or IOP lowering …See details»
EYEGENIX - VentureRadar
Eyegenix has the exclusive worldwide commercial rights to a biosynthetic artificial corneal material for transplantation, which holds the potential... ... Find out ...See details»
Eyegenex - 2025 Company Profile, Funding
Feb 24, 2025 Eyegenex. has raised a total funding of $745K over 1 round. What are the most recent funding rounds of Eyegenex? Its latest funding round was a Seed round on Sep 07, 2023 for $745K . 2 investor s participated in its latest …See details»
Revolutionizing Ophthalmic Care: Exploring Eyegenex …
Feb 2, 2024 • Eyegenex’s pioneering work in gene and peptide therapies for ophthalmic conditions • The personal journey and insights driving Prasad’s commitment to advancing ophthalmology. For a deep dive into this thought …See details»
Eyegenix - Crunchbase Company Profile & Funding
Eyegenix, LLC develops a biosynthetic artificial corneal material for transplantation to cure corneal blindness. The company was incorporated in 2009 and is based in Honolulu, Hawaii.See details»
NuFund Venture Group Highlights Eyegenex's Innovative ... - citybiz
Jul 15, 2024 Eyegenex is a leading biotechnology company focused on developing innovative treatments for a range of eye conditions. Utilizing advanced gene and peptide therapy, …See details»
Steve Gormican, MD - Chief Medical Officer - Eyegenex - LinkedIn
Eyegenex is developing several drugs to prevent blindness in glaucoma. · Experience: Eyegenex · Education: University of Toronto · Location: San Diego County · 500+ connections on LinkedIn.See details»
Publications - Eyegenex
Eyegenex has recently gathered promising data on their drug candidate, CPP-P1, designed to fight the rising number of blindness cases in patients with glaucoma and non-arteritic anterior …See details»
Prasad Sunkara, Ph. D on LinkedIn: OIS XIII - Eyegenex
Eyegenex is one of the startup companies selected to present at Opthalmology Investor Summit. This would be our team’s first presentation of our innovative gene and peptide therapies for the ...See details»
Eyegenex Management Team - CB Insights
Eyegenex Management Team2 Team Members. Eyegenex has 2 executives. Eyegenex's current Chief Executive Officer is Prasad Sunkara. Name. Work History. Title. Status. Prasad …See details»
Eyegenix - Contacts, Employees, Board Members, Advisors & Alumni
Eyegenix develops a biosynthetic artificial corneal material for transplantation to cure corneal blindness.See details»
OIS XIV 2024 Presenting Companies | Ophthalmology Innovation …
Prasad Sunkara, President & CEO - Eyegenex Eyegenex,Inc is a US based biotech company focusing on the development of gene and peptide therapies for Glaucoma and diabetic …See details»
Oculogenex | Using gene therapy to improve vision for our …
MassChallenge is a non-profit organization dedicated to supporting innovation and entrepreneurship through collaboration and development. SBIR Grant Awarded to Oculogenex …See details»